Emerging nanotechnological approaches to regulating tumor vasculature for cancer therapy

Chunling Wang1, Junchao Xu2, Yinlong Zhang3

  • 1CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China; Sino-Danish Center for Education and Research, Sino-Danish College of UCAS, Beijing 100190, China.

Insights

Abnormal tumor angiogenesis creates a hostile environment for cancer. Nanomedicines offer precise vascular regulation, improving drug delivery and reducing toxicity for enhanced cancer therapy.

Area of Science:

  • Oncology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Abnormal tumor angiogenesis is a hallmark of cancer, creating a unique microenvironment that supports tumor growth and metastasis.
  • Tumor vasculature is structurally and functionally distinct from normal vasculature, presenting challenges for drug delivery.
  • Vascular-targeting drugs and nanomedicines offer strategies to disrupt tumor blood supply and enhance therapeutic outcomes.

Purpose of the Study:

  • To review the characteristics of tumor blood vessels and identify key molecular targets for nanomedicine design.
  • To highlight advancements in nanotechnologies for precise regulation of tumor vasculature.
  • To discuss challenges and future directions in nanomedicine for cancer therapy.

Main Methods:

  • Review of current literature on tumor angiogenesis and nanomedicine.
  • Analysis of molecular targets in tumor vasculature relevant to nanomedicine design.
  • Synthesis of recent research on nanotechnologies for vascular regulation in cancer.

Main Results:

  • Nanomedicines enable precise regulation of tumor vasculature and co-delivery of therapeutics.
  • Functional motifs in nanomedicines improve tissue accumulation, penetration, and controlled release.
  • Targeting tumor vasculature with nanomedicines reduces systemic toxicity and enhances therapeutic efficacy.

Conclusions:

  • Nanomedicines represent a promising approach for precise regulation of tumor vasculature.
  • Targeted nanomedicine design can overcome limitations of conventional cancer therapies.
  • Further research is needed to address challenges and optimize nanomedicine applications in oncology.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K